Renaissance Capital logo

Sienna Biopharmaceuticals Priced, Nasdaq: SNNA

Clinical-stage biotech developing topical therapies for dermatological conditions.

Industry: Health Care

First Day Return: +28.3%

Industry: Health Care

We are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. Our objective is to develop our multi-asset pipeline of topical therapies that enhance the health, appearance and quality of life of dermatology patients. We are advancing multiple product candidates derived from our Topical by Design platform, all of which are designed to be suitable for chronic administration in patients with inflammatory skin diseases and other dermatologic and aesthetic conditions. Our lead candidate from this platform, SNA-120, is a first-in-class inhibitor of TrkA in Phase 2b clinical development for the treatment of pruritus, or itch, associated with psoriasis, as well as for psoriasis itself. Our second Topical by Design product candidate, SNA-125, is a dual JAK3/TrkA inhibitor being developed for the treatment of atopic dermatitis, psoriasis and pruritus. Additionally, we have advanced SNA-001, a silver particle treatment derived from our Topical Photoparticle Therapy platform, into pivotal clinical trials for both acne vulgaris and the reduction of unwanted light-pigmented hair.
more less
IPO Data
IPO File Date 07/05/2017
Offer Price $15.00
Price Range $14.00 - $16.00
Offer Shares (mm) 4.3
Deal Size ($mm) $65
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/26/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $65
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Westlake Village, CA, United States
Founded 2010
Employees at IPO 43
Website www.SiennaBio.com

Sienna Biopharmaceuticals (SNNA) Performance